UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 27, 2026
Exercise
Calculated transaction value
$0
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jul 24, 2026
Public filing date
Jul 27, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$528.47
Jul 24, 2026
Close before public filing
$528.47
Jul 24, 2026
Return since public filing
-4.66%
Through Sep 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option on Common Stock
- Quantity / price
- 9,500 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000106
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$6.34M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Jul 24, 2026 | $1.45M |
| United Therapeutics Corp UTHR Current | Exercise | Jul 24, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Jul 24, 2026 | $60.46K |
| United Therapeutics Corp UTHR | Sale | Jul 24, 2026 | $433.55K |
| United Therapeutics Corp UTHR | Sale | Jul 24, 2026 | $592.18K |
| United Therapeutics Corp UTHR | Exercise | Jul 24, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jul 24, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Sale | Jul 24, 2026 | $969.36K |
| United Therapeutics Corp UTHR | Sale | Jul 24, 2026 | $336.67K |